199296-39-4 Usage
Uses
Used in Organic Synthesis:
2-Pyridineethanamine,beta,beta-dimethyl-(9CI) is used as a key intermediate in organic synthesis for the production of various pharmaceuticals and biologically active molecules. Its unique chemical structure allows for the creation of a wide range of compounds with diverse applications.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-Pyridineethanamine,beta,beta-dimethyl-(9CI) is utilized as a starting material or building block in the development of new drugs. Its potential biological activities make it a promising candidate for the treatment of various diseases and conditions.
Used in Medicinal Chemistry:
2-Pyridineethanamine,beta,beta-dimethyl-(9CI) is employed in medicinal chemistry for the design and synthesis of novel compounds with potential therapeutic properties. Its unique structure and reactivity contribute to the discovery of new pharmaceutical agents.
Used in Pharmaceutical Development:
In the field of pharmaceutical development, 2-Pyridineethanamine,beta,beta-dimethyl-(9CI) plays a crucial role in the synthesis and optimization of drug candidates. Its properties facilitate the development of innovative medications with improved efficacy and safety profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 199296-39-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,9,2,9 and 6 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 199296-39:
(8*1)+(7*9)+(6*9)+(5*2)+(4*9)+(3*6)+(2*3)+(1*9)=204
204 % 10 = 4
So 199296-39-4 is a valid CAS Registry Number.
199296-39-4Relevant academic research and scientific papers
Rhodium(III)-Catalyzed Activation of Csp3 -H Bonds and Subsequent Intermolecular Amidation at Room Temperature
Huang, Xiaolei,Wang, Yan,Lan, Jingbo,You, Jingsong
supporting information, p. 9404 - 9408 (2015/08/06)
Disclosed herein is a RhIII-catalyzed chelation-assisted activation of unreactive Csp3-H bonds, thus enabling an intermolecular amidation to provide a practical and step-economic route to 2-(pyridin-2-yl)ethanamine derivatives. Substrates with other N-donor groups are also compatible with the amidation. This protocol proceeds at room temperature, has a relatively broad functional-group tolerance and high selectivity, and demonstrates the potential of rhodium(III) in the promotive functionalization of unreactive Csp3-H bonds. A rhodacycle having a SbF6- counterion was identified as a plausible intermediate. Giving direction: The title reaction leads to the successful functionalization of unreactive Csp3-H bonds in the presence of directing groups (DGs). A rhodacycle having a SbF6- counterion was isolated and is proposed to be a plausible intermediate.
ACYCLIC IKUR INHIBITORS
-
Page/Page column 82, (2010/11/26)
A compound of formula I wherein R1, R2, R3, R4 and R5 are described herein.
PYRAZINONE THROMBIN INHIBITORS
-
, (2008/06/13)
Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the following structure: STR1 for example: STR2
